SHA:600557 Revenue

Jiangsu Kanion Pharmaceutical had revenue of 701.11M CNY in the quarter ending September 30, 2025, a decrease of -17.42%. This brings the company's revenue in the last twelve months to 3.13B, down -29.97% year-over-year. In the year 2024, Jiangsu Kanion Pharmaceutical had annual revenue of 3.90B, down -19.86%.

Revenue (ttm)

3.13B

Revenue Growth

-29.97%

P/S Ratio

2.53

Revenue / Employee

511.02K

Employees

6,132

Market Cap

7.92B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	3.90B	-966.15M	-19.86%
Dec 31, 2023	4.86B	512.95M	11.79%
Dec 31, 2022	4.35B	702.30M	19.25%
Dec 31, 2021	3.65B	616.64M	20.34%
Dec 31, 2020	3.03B	-1.53B	-33.59%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Sunflower Pharmaceutical Group Co.,Ltd	2.09B
Hubei Hongyuan Pharmaceutical Technology	1.77B
Zhejiang Tianyu Pharmaceutical	2.99B
Changchun BCHT Biotechnology Co.	591.81M
Sichuan Huiyu Pharmaceutical	998.15M
China Animal Husbandry Industry	6.28B
Renhe Pharmacy Co.,Ltd	3.76B
Guangxi Wuzhou Zhongheng Group	2.29B

Revenue Rankings